Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathway

Oncotarget

Volumn 5, Issue 8, 2014, Pages 2077-2084

  Gao, Xiaoge ^a,b   Balan, Balan ^a,c   Tai, Guihua ^b   Raz, Avraham ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHEAST NORMAL UNIVERSITY   (China)

^c Everon Biosciences   (United States)

Author keywords

Calcium ions; Cell migration; Extracellular signal regulated protein kinase1 2; Galectin 3; Protein kinase c

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; GALECTIN 3; GEFITINIB; LACTOSE; MITOGEN ACTIVATED PROTEIN KINASE 1; PAXILLIN; PROTEIN KINASE B; TYROSINE; SMALL INTERFERING RNA;

ARTICLE; BIOLOGICAL ACTIVITY; CALCIUM CELL LEVEL; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DISEASE MARKER; DOSE RESPONSE; ENZYME ACTIVATION; FOCAL ADHESION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; CELL MOTION; GENETIC TRANSFECTION; GENETICS; HELA CELL LINE; METABOLISM; PHYSIOLOGY; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL MOVEMENT; ENZYME ACTIVATION; GALECTIN 3; HELA CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84899557252     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1786     Document Type: Article

References (38)

1. Dumic J, Dabelic S, Flögel M. Galectin-3: An open-ended story. Biochimica et Biophysica Acta - General Subjects. 2006; 1760: 616-635.
2. Lepur A, Salomonsson E, Nilsson UJ, Leffler H. Ligand induced galectin-3 protein self-association. Journal of Biological Chemistry. 2012 287: 21751-21756.
3. Gong HC, Honjo Y, Nangia-Makker P, Hogan V, Mazurak N, Bresalier RS, Raz A. The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells. Cancer Research. 1999; 59: 6239-6245.
4. Haudek KC, Spronk KJ, Voss PG, Patterson RJ, Wang JL, Arnoys EJ. Dynamics of galectin-3 in the nucleus and cytoplasm. Biochimica et Biophysica Acta - General Subjects. 2010; 1800: 181-189.
5. Hughes RC. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochimica et Biophysica Acta. 1999; 1473: 14: 172-185.
6. Gabriel A. Rabinovich LGB, Nicola Tinari, Roberto Paganelli, Clara Natoli,, Iacobelli F-TlaS. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? TRENDS in Immunology. 2002; 23: 313-320.
7. Seve AP, Hadj-Sahraoui Y, Felin M, Doyennette-Moyne MA, Aubery M, Hubert J. Evidence that lactose binding to CBP35 disrupts its interaction with CBP70 in isolated HL60 cell nuclei. Experimental Cell Research. 1994; 213: 191-197.
8. Ochieng J, Furtak V, Lukyanov P. Extracellular functions of galectin-3. Glycoconjugate Journal. 2002; 19: 527-535.
9. Liu FT, Patterson RJ, Wang JL. Intracellular functions of galectins. Biochimica et Biophysica Acta - General Subjects. 2002; 1572: 263-273.
10. Sundblad V, Croci DO, Rabinovich GA. Regulatedexpression of galectin-3, a multifunctional glycan-binding protein, in haematopoietic and non-haematopoietic tissues. Histology and Histopathology. 2011; 26: 247-265.
11. Noël JC, Chapron C, Borghese B, Fayt I, Anaf V. Galectin-3 is overexpressed in various forms of endometriosis. Applied Immunohistochemistry and Molecular Morphology. 2011; 19: 253-257.
12. Iurisci I, Tinari N, Natoli C, Angelucci D, Cianchetti E, Iacobelli S. Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clinical Cancer Research. 2000; 6: 1389-1393.
13. Vereecken, P., A. Awada, S. Suciu, G. Castro, R. Morandini, A. Litynska, D. Lienard, K. Ezzedine, G. Ghanem, and M. Heenen. 2009. Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients. Melanoma Research. 19: 316-320.
14. Balan V, Wang Y, Nangia-Makker P, Kho D, Bajaj M, Smith D Heilbrun L, Raz A, Heath E. Galectin-3: A possible complementary marker to the PSA blood test. Oncotarget. 2013; 4: 542-549.
15. Wang X, Zhang S, Faliang Lin, Wenzheng Chu and Shouwei Yue. Elevated Galectin-3 Levels in the Serum of Patients With Alzheimer's Disease. American Journal of Alzheimer's Disease & Other Dementias. 2013; DOI: 10.1177/1533317513495107
16. Lee YJ, Kang SW, Song JK, Park JJ, Bae YD, Lee EY, Lee EB, Song YW. Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity. Clinical and Experimental Rheumatology. 2007; 25: S41-S45.
17. Schmitter D, Cotter G, Voors AA. Clinical use of novel biomarkers in heart failure: towards personalized medicine. Heart Failure Reviews: 2013, DOI 10.1007/s10741-013- 9396-5.
18. Lee YM, Lee JB. Prognostic value of epidermal growth factor receptor, p53 and galectin-3 expression in papillary thyroid carcinoma. Journal of International Medical Research. 2013; 41: 825-834.
19. Fukumori T, Takenaka Y, Yoshii T, Kim HRC, Hogan V, Inohara H, Kagawa S, Raz A. CD29 and CD7 Mediate Galectin-3-Induced Type II T-Cell Apoptosis. Cancer Research. 2003; 63: 8302-8311.
20. Lepur A, Carlsson MC, Novak R, Dumic J, Nilsson UJ, Leffler H.. Galectin-3 endocytosis by carbohydrate independent and dependent pathways in different macrophage like cell types. Biochimica et Biophysica Acta - General Subjects. 2012, 1820: 804-818.
21. Gao X, Liu D, Fan Y, Li X, Xue H, Ma Y, Zhou Y, Tai G. The Two Endocytic Pathways Mediated by the Carbohydrate Recognition Domain and Regulated by the Collagen-like Domain of Galectin-3 in Vascular Endothelial Cells. PLoS ONE. 2012; 7: e52430.
22. Schneider D, Greb C, Koch A, Straube T, Elli A, Delacour D, Jacob R. Trafficking of galectin-3 through endosomal organelles of polarized and non-polarized cells. European Journal of Cell Biology. 2010; 89: 788-798.
23. Jo M, Thomas KS, O'Donnell DM, Gonias SL. Epidermal growth factor receptor-dependent and -independent cellsignaling pathways originating from the urokinase receptor. Journal of Biological Chemistry. 2013; 278: 1642-1646.
24. Nowycky MC, Thomas AP. Intracellular calcium signaling. Journal of Cell Science. 2002; 115: 3715-3716.
25. Carafoli E. Calcium signaling: A tale for all seasons. Proceedings of the National Academy of Sciences of the United States of America. 2002; 99: 1115-1122.
26. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marme D, Rapp UR. Protein kinase C[alpha] activates RAF-1 by direct phosphorylation. Nature. 1993; 364: 249-252.
27. Wen-Sheng W. Protein kinase C a trigger Ras and Rafindependent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2. Cancer Letters. 2006; 239: 27-35.
28. Yamaguchi H, Wyckoff J, Condeelis J. Cell migration in tumors. Current Opinion in Cell Biology. 2005; 17: 559- 564.
29. Kim S, Choi I, Cheong T, Lee S, Lotan R, Park SH, Chun K. Galectin-3 Increases Gastric Cancer Cell Motility by Upregulating Fascin-1 Expression. Gastroenterology. 2010; 138: 1035-1045.
30. Hsu DK, Chernyavsky AI, Chen HY, Yu L, Grando SA, Liu FT. Endogenous galectin-3 is localized in membrane lipid rafts and regulates migration of dendritic cells. Journal of Investigative Dermatology. 2009; 129: 573-583.
31. Hittelet A, Legendre H, Nagy N, Bronckart Y, Pector JC, Salmon I, Yeaton P, Gabius HJ, Kiss R, Camby I. Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration. International Journal of Cancer. 2003; 103: 370-379.
32. Schaller MD. Paxillin: A focal adhesion-associated adaptor protein. Oncogene. 2011; 20: 6459-6472.
33. Carnero, A. The PKB/AKT pathway in cancer. Current Pharmaceutical Design. 2010; 16: 34-44.
34. Chen H, Zhu G, Li Y, Padia RN, Dong Z, Pan ZK, Liu K, Huang S Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. Cancer Research. 2009; 69: 9228-9235.
35. Hu CT, Cheng CC, Pan SM, Wu JR, Wu WS. PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2. Cellular Signalling. 2013; 25: 1457-1467.
36. Novak R, Jacob E, Haimovich J, Avni O, Melamed D. The MAPK/ERK and PI(3)K pathways additively coordinate the transcription of recombination-activating genes in B lineage cells. Journal of Immunology. 2010; 185: 3239-3247.
37. McCubrey JA, Steelman LS, Chappell WH, Abrams SL,Wong EWT, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, Stivala F, Libra M, Basecke J, Evangelisti C, Martelli AM, Franklin RA. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochimica et Biophysica Acta - Molecular Cell Research. 2007; 1773: 1263-1284.
38. Levi G, Teichberg VI. Isolation and physicochemical characterization of electrolectin, a beta-D-galactoside binding lectin from the electric organ of Electrophorus electricus. Journal of Biological Chemistry. 1981; 256: 5735-5740.